InspireMD, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
NSPR Nasdaq 3850 www.inspiremd.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for InspireMD, Inc.

InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures - Jun 8th, 2026 6:00 am
InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference - May 6th, 2026 2:05 pm
InspireMD, Inc. Q1 2026 Earnings Call Summary - May 5th, 2026 6:30 am
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates - May 4th, 2026 3:50 pm
InspireMD (NSPR) Q4 2025 Earnings Transcript - May 4th, 2026 3:28 pm
InspireMD (NSPR) Q2 2025 Earnings Transcript - May 4th, 2026 3:26 pm
InspireMD Reports First Quarter 2026 Financial Results - May 4th, 2026 2:05 pm
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System - May 1st, 2026 2:05 pm
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System - May 1st, 2026 2:05 pm
InspireMD to Announce First Quarter 2026 Financial Results - Apr 27th, 2026 2:05 pm
After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR) - Apr 8th, 2026 7:35 am
InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference - Mar 31st, 2026 2:05 pm
InspireMD Inc (NSPR) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advancements - Mar 18th, 2026 1:02 pm
InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates - Mar 18th, 2026 6:15 am
InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results - Mar 18th, 2026 5:00 am
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results - Mar 9th, 2026 7:00 am
NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates - Mar 3rd, 2026 3:35 pm
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 20th, 2026 7:00 am
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) - Jan 12th, 2026 7:00 am
InspireMD (NASDAQ:NSPR) shareholders have endured a 81% loss from investing in the stock five years ago - Jan 10th, 2026 7:41 am